Aliases & Classifications for Cellulitis

Summaries for Cellulitis

MedlinePlus : 40 Cellulitis is an infection of the skin and deep underlying tissues. Group A strep (streptococcal) bacteria are the most common cause. The bacteria enter your body when you get an injury such as a bruise, burn, surgical cut, or wound. Symptoms include Fever and chills Swollen glands or lymph nodes A rash with painful, red, tender skin. The skin may blister and scab over. Your health care provider may take a sample or culture from your skin or do a blood test to identify the bacteria causing infection. Treatment is with antibiotics. They may be oral in mild cases, or intravenous (by IV) for more severe cases. NIH: National Institute of Allergy and Infectious Diseases

MalaCards based summary : Cellulitis is related to wells syndrome and lymphedema, hereditary, ii, and has symptoms including pruritus, fever and exanthema. An important gene associated with Cellulitis is IL5 (Interleukin 5), and among its related pathways/superpathways are Bacterial infections in CF airways and Hematopoietic cell lineage. The drugs Clindamycin and Lincomycin have been mentioned in the context of this disorder. Affiliated tissues include skin, testes and lymph node, and related phenotype is immune system.

Disease Ontology : 12 A skin disease where there is a diffuse infection of connective tissue with severe inflammation of dermal and subcutaneous layers of the skin. Cellulitis can be caused by normal skin flora or by exogenous bacteria, and often occurs where the skin has previously been broken

Wikipedia : 72 Cellulitis is a bacterial infection involving the inner layers of the skin. It specifically affects the... more...

Related Diseases for Cellulitis

Diseases related to Cellulitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 395)
# Related Disease Score Top Affiliating Genes
1 wells syndrome 32.9 CRP IL1R1 IL5 RNASE3
2 lymphedema, hereditary, ii 31.3 CAMP GJC2
3 sinusitis 30.7 DEFB4A IL5 RNASE3
4 scleritis 30.2 IL5 TNF
5 bacteremia 2 30.2 CRP LACTB
6 folliculitis 29.9 DEFB4A IL5
7 churg-strauss syndrome 29.6 IL5 RNASE3 TNF
8 keratoconjunctivitis 29.6 IL5 RNASE3 TNF
9 pneumonia 29.6 CRP IL5 LACTB TNF
10 meningitis 29.5 CRP LACTB TNF
11 diverticulitis 29.4 CRP TNF
12 endocarditis 29.4 CRP LACTB TNF
13 pyomyositis 29.4 CRP SUCLG2
14 spondylitis 29.2 CHI3L1 CRP TNF
15 rheumatoid arthritis 29.1 CHI3L1 CRP IL1R1 TNF
16 orbital cellulitis 12.4
17 perifolliculitis capitis abscedens et suffodiens, familial 12.0
18 tinea unguium 11.3
19 erysipelas 11.2
20 parametritis 11.2
21 ludwig's angina 11.2
22 lacrimal duct defect 11.1
23 erysipeloid 11.1
24 nocardiosis 11.1
25 lymphedema, hereditary, ia 10.8
26 whim syndrome 10.8
27 fusariosis 10.8
28 clear cell acanthoma 10.8
29 elizabethkingia anophelis infection 10.8
30 vulvar vestibulitis syndrome 10.5 IL1R1 TNF
31 angioimmunoblastic lymphadenopathy with dysproteinemia 10.5 IL5 TNF
32 loeffler endocarditis 10.5 IL5 RNASE3
33 paratyphoid fever 10.5 IL1R1 TNF
34 cold urticaria 10.5 IL1R1 RNASE3
35 paragonimiasis 10.5 IL5 RNASE3
36 cough variant asthma 10.5 IL5 RNASE3
37 atopic keratoconjunctivitis 10.5 IL5 RNASE3
38 cardiac sarcoidosis 10.5 IL5 TNF
39 cow milk allergy 10.5 IL5 RNASE3
40 intrinsic asthma 10.5 IL5 RNASE3
41 inflammatory bowel disease 4 10.5 IL5 RNASE3
42 eosinophilic gastroenteritis 10.5 IL5 RNASE3
43 chronic eosinophilic pneumonia 10.5 IL5 RNASE3
44 gastrointestinal allergy 10.4 IL5 RNASE3
45 latex allergy 10.4 IL5 RNASE3
46 urinary schistosomiasis 10.4 IL5 RNASE3
47 chronic conjunctivitis 10.4 IL5 RNASE3
48 status asthmaticus 10.4 IL5 RNASE3
49 kimura disease 10.4 IL5 RNASE3
50 vernal keratoconjunctivitis 10.4 IL5 RNASE3

Graphical network of the top 20 diseases related to Cellulitis:



Diseases related to Cellulitis

Symptoms & Phenotypes for Cellulitis

UMLS symptoms related to Cellulitis:


pruritus, fever, exanthema

MGI Mouse Phenotypes related to Cellulitis:

43
# Description MGI Source Accession Score Top Affiliating Genes
1 immune system MP:0005387 9.23 CAMP CHI3L1 CRP FLT4 GJC2 IL1R1

Drugs & Therapeutics for Cellulitis

Drugs for Cellulitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 172)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Clindamycin Approved, Vet_approved Phase 4,Phase 2,Phase 3 18323-44-9 29029
2
Lincomycin Approved, Vet_approved Phase 4 154-21-2 656509
3
Penicillin V Approved, Vet_approved Phase 4 87-08-1 6869
4
Daptomycin Approved, Investigational Phase 4,Phase 2 103060-53-3 16129629
5
Vancomycin Approved Phase 4,Phase 3,Phase 2 1404-90-6 14969 441141
6
Oxacillin Approved, Investigational Phase 4,Phase 2 66-79-5 6196
7
Thrombin Approved, Investigational Phase 4
8
Acetylcysteine Approved, Investigational Phase 4 616-91-1 12035
9
Lenograstim Approved, Investigational Phase 4 135968-09-1
10
Pentoxifylline Approved, Investigational Phase 4 6493-05-6 4740
11 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2
12 Anti-Infective Agents Phase 4,Phase 3,Phase 2
13 Clindamycin palmitate Phase 4,Phase 2,Phase 3
14 Clindamycin phosphate Phase 4,Phase 2,Phase 3
15 Floxacillin Phase 4
16 Antibiotics, Antitubercular Phase 4,Phase 2,Phase 3
17 penicillins Phase 4,Phase 2
18 Arginine Vasopressin Phase 4
19 Coagulants Phase 4
20 Hemostatics Phase 4
21 Natriuretic Agents Phase 4
22 Vasoconstrictor Agents Phase 4
23 Vasopressins Phase 4
24 acivicin Phase 4
25 Antiviral Agents Phase 4
26 Respiratory System Agents Phase 4
27 Antitubercular Agents Phase 4
28 methicillin Phase 4,Phase 2,Phase 3
29 Adjuvants, Immunologic Phase 4
30 Antidotes Phase 4
31 Antioxidants Phase 4
32 diuretics Phase 4
33 Expectorants Phase 4
34 Liver Extracts Phase 4
35 N-monoacetylcystine Phase 4
36 Pharmaceutical Solutions Phase 4,Phase 3
37 Protective Agents Phase 4
38 arginine Nutraceutical Phase 4
39 cysteine Nutraceutical Phase 4
40
Cefazolin Approved Phase 3,Phase 2 25953-19-9 33255 656510
41
Estradiol Approved, Investigational, Vet_approved Phase 3 50-28-2 5757
42
Ethinyl Estradiol Approved Phase 3 57-63-6 5991
43
Moxifloxacin Approved, Investigational Phase 3 151096-09-2, 354812-41-2 152946
44
Norgestimate Approved, Investigational Phase 3 35189-28-7 6540478
45
Probenecid Approved, Investigational Phase 3,Phase 2 57-66-9 4911
46
Ciprofloxacin Approved, Investigational Phase 2, Phase 3 85721-33-1 2764
47
Levofloxacin Approved, Investigational Phase 2, Phase 3 100986-85-4 149096
48
Ofloxacin Approved Phase 2, Phase 3 82419-36-1 4583
49
Cilastatin Approved, Investigational Phase 3 82009-34-5 6435415 5280454
50
Imipenem Approved Phase 3 64221-86-9, 74431-23-5 104838

Interventional clinical trials:

(show top 50) (show all 122)

# Name Status NCT ID Phase Drugs
1 Adjunctive Clindamycin for Cellulitis: C4C Trial. Unknown status NCT01876628 Phase 4 Flucloxacillin and Clindamycin;Flucloxacillin and placebo
2 RCT to Investigate if Prophylactic Antibiotics Prevent Further Episodes of Cellulitis (Erysipelas) of the Leg Completed NCT00552799 Phase 4 Penicillin VK
3 Study Comparing CUBICIN® (Daptomycin for Injection) With Vancomycin in Cellulitis or Erysipelas Completed NCT00295178 Phase 4 Daptomycin;Vancomycin
4 The Effects of Daptomycin and Cytokines Production in Comparison With Vancomycin Completed NCT01626560 Phase 4 Daptomycin;Vancomycin
5 Evaluation of Daptomycin for the Emergency Department Treatment of Complicated Skin and Skin Structure Infections Completed NCT01549613 Phase 4 Daptomycin;Vancomycin
6 Comparison of the Effects of Cervical Vasopressin Versus no Premedication on Blood Loss During Vaginal Hysterectomy: A Randomized, Placebo Controlled Trial Completed NCT00799292 Phase 4 Vasopressin
7 Use of Negative Pressure Wound Therapy in High Risk Surgical Closed Incisions Completed NCT02137447 Phase 4
8 A Complicated Skin and Soft-tissue Infection Patient Registry Completed NCT00737269 Phase 4
9 Study of Wound Packing After Superficial Skin Abscess Drainage Completed NCT00746109 Phase 4
10 Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty Completed NCT01410240 Phase 4 FLOSEAL Hemostatic Matrix + Standard of care
11 G-CSF Plus NAC In Severe Alcoholic Hepatitis Recruiting NCT02971306 Phase 4 standard medical therapy;G-CSF;n-Acetylcysteine
12 Penicillin for the Emergency Department Outpatient Treatment of CELLulitis Not yet recruiting NCT02922686 Phase 4 Flucloxacillin;Phenoxymethylpenicillin;Placebo (for phenoxymethylpenicillin)
13 Duration of ANtibiotic Therapy for CEllulitis Terminated NCT02032654 Phase 4 Flucloxacillin;Placebo (for flucloxacillin)
14 Safety and Efficacy of Daptomycin for the Treatment of Complicated Skin and Skin-structure Infections Terminated NCT00463801 Phase 4 Daptomycin
15 Use of Santyl Within an Accountable Care Organization Withdrawn NCT02716519 Phase 4
16 Oral Moxifloxacin Versus Cefazolin and Oral Probenecid in the Management of Skin and Soft Tissue Infections in the Emergency Department Unknown status NCT00323219 Phase 3 Cefazolin and Moxifloxacin
17 A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Oral Ciprofloxacin in the Treatment of Adults With Mild to Moderate Infections of the Skin and the Supportive Layers Beneath the Skin Completed NCT00257036 Phase 2, Phase 3 levofloxacin
18 Incision and Drainage Versus Needle Aspiration in Soft Tissue Abscesses Completed NCT01085929 Phase 3
19 Complicated Skin and Skin Structure Infections Completed NCT00619710 Phase 3 Meropenem;Imipenem-cilastatin
20 Strategies Using Off-Patent Antibiotics for Methicillin Resistant S. Aureus "STOP MRSA" Completed NCT00729937 Phase 2, Phase 3 Cephalexin;Clindamycin;Trimethoprim-sulfamethoxazole
21 Evaluation of the Activity of a Pharmacological "Anticellulitis" Product vs. a Reference Product on the Market Completed NCT02195297 Phase 3
22 Single Dose vs. Two Dose Regimen of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections Completed NCT02127970 Phase 3 Single Dose Dalbavancin;Two Dose Dalbavancin
23 Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections Completed NCT01431339 Phase 3 IV Dalbavancin;Vancomycin/Linezolid
24 Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections Completed NCT01339091 Phase 3 Dalbavancin;Vancomycin / Linezolid
25 Oritavancin Versus IV Vancomycin for the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infection Completed NCT01252732 Phase 3 Single-Dose IV Oritavancin Diphosphate;IV Vancomycin
26 Oritavancin Versus IV Vancomycin for the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infection Completed NCT01252719 Phase 3 Single-Dose IV Oritavancin Diphosphate;IV Vancomycin
27 Prospective Randomized Trial of Bactrim on 7 Day Outcome in Patients With Uncomplicated Abscesses Completed NCT00973765 Phase 3 bactrim;placebo
28 Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease Completed NCT01576367 Phase 3
29 Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease Completed NCT01302860 Phase 3 ACZ885
30 Efficacy and Safety Study of Canakinumab Administered for 6 Months (24 Weeks) in Japanese Patients With Cryopyrin-associated Periodic Syndromes Followed by an Extension Phase Completed NCT00991146 Phase 3 canakinumab
31 Efficacy and Safety of ACZ885 in Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease Completed NCT00685373 Phase 3 Canakinumab (ACZ885)
32 Efficacy, Safety, and Tolerability of ACZ885 in Patients With Muckle-Wells Syndrome Completed NCT00465985 Phase 3 ACZ885;Placebo
33 Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections Completed NCT01499277 Phase 3 Ceftaroline fosamil;Vancomycin;Aztreonam
34 Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections Completed NCT00424190 Phase 3 IV Vancomycin plus IV Aztreonam;Ceftaroline
35 Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections Completed NCT00423657 Phase 3 ceftaroline;vancomycin plus aztreonam;Placebo
36 A Study to Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatric Population 5 Through 17 Years of Age Completed NCT02545543 Phase 3
37 A Study to Evaluate the Immunogenicity and Safety of bioCSL Quadrivalent Influenza Vaccine (QIV) in Adults Aged 18 Years and Above. Completed NCT02214225 Phase 3
38 A Study to Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatric Population 6 Months Through 59 Months of Age. Completed NCT02914275 Phase 3
39 Study the Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI) Terminated NCT00865280 Phase 3 PTK 0796;linezolid
40 Evaluation of Ceftaroline Fosamil vs Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections. Terminated NCT02202135 Phase 3 Ceftaroline fosamil;Vancomycin;Aztreonam
41 Flexitouch® Home Maintenance Therapy or Standard Home Maintenance Therapy in Treating Patients With Lower-Extremity Lymphedema Caused by Treatment for Cervical Cancer, Vulvar Cancer, or Endometrial Cancer Terminated NCT00577317 Phase 3
42 Phase 3 Study - Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI) Withdrawn NCT00876850 Phase 3 PTK 0796;Linezolid
43 Comparison of Intravenous Cefazolin Plus Oral Probenecid With Oral Cephalexin for the Treatment of Cellulitis Completed NCT01029782 Phase 2 IV cefazolin plus oral probenecid and placebo cephalexin;Oral cephalexin and saline IV plus probenecid placebo
44 A Phase 2 Safety and Exploratory Skin Lesion Measurement of TR-701 FA Study Completed NCT01519778 Phase 2 TR701 FA
45 Uncomplicated Skin and Soft Tissue Infections Caused by Community-Associated Methicillin-Resistant Staphylococcus Aureus Completed NCT00730028 Phase 2 Trimethoprim-sulfamethoxazole;Clindamycin
46 Aquacel Versus Iodoform Gauze for Filling Abscess Cavity Following Incision and Drainage Completed NCT00984022 Phase 2
47 The Effect of the Cosmetic Cream NMBM on Leg Ulcers - a Pilot Study Completed NCT01770509 Phase 1, Phase 2
48 A Study of Safety, Tolerability, and Efficacy of AFN-12520000 in the Treatment of Acute Bacterial Skin and Skin Structure Infections Due to Staphylococci Completed NCT01519492 Phase 2 AFN-12520000
49 A Study for Patients With Complicated Skin and Skin Structure Infections Completed NCT00514527 Phase 2 oritavancin
50 Phase 2 Trial of TD 6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI) Completed NCT00061633 Phase 2 Telavancin;Vancomycin or antistaphylococcal penicillin

Search NIH Clinical Center for Cellulitis

Cochrane evidence based reviews: cellulitis

Genetic Tests for Cellulitis

Genetic tests related to Cellulitis:

# Genetic test Affiliating Genes
1 Cellulitis 28

Anatomical Context for Cellulitis

MalaCards organs/tissues related to Cellulitis:

38
Skin, Testes, Lymph Node, Breast, T Cells, Bone, Eye

Publications for Cellulitis

Articles related to Cellulitis:

(show top 50) (show all 1152)
# Title Authors Year
1
Wells syndrome (eosinophilic cellulitis) caused by adrenal insufficiency and relieved by cortisone supplementation. ( 29398098 )
2018
2
Cellulitis and Soft Tissue Infections. ( 29404597 )
2018
3
Treatment of a Klebsiella pneumoniae KPC cellulitis and gut decolonization with ceftazidime/avibactam in a migrant from Libya. ( 29336224 )
2018
4
Hospital cost analysis of children with preseptal cellulitis. ( 29447901 )
2018
5
Indicators for imaging in periorbital cellulitis secondary to rhinosinusitis. ( 29450710 )
2018
6
Non-invasive assessment of cellulitis from snapshot hyperspectral imaging - A primary study. ( 29368433 )
2018
7
The epidemiology and risk factors for recurrent severe lower limb cellulitis: a longitudinal cohort study. ( 29427799 )
2018
8
Variation in Care and Clinical Outcomes in Children Hospitalized With Orbital Cellulitis. ( 29208694 )
2018
9
Clinical characteristics affecting length of stay in patients with cellulitis. ( 29415341 )
2018
10
Tinea capitis mimicking dissecting cellulitis in three children. ( 29265536 )
2018
11
Dissecting Cellulitis of the Scalp: A Rare Dermatological Manifestation of Crohn's Disease. ( 29430467 )
2018
12
Severe lower limb cellulitis: defining the epidemiology and risk factors for primary episodes in a population-based case-control study. ( 29427797 )
2018
13
Clinical Course of Preseptal and Orbital Cellulitis in 50 Immunocompromised Patients with Cancer. ( 29128228 )
2018
14
Non-tender recurrent scrotal cellulitis. ( 29440333 )
2018
15
Disseminated cryptococcosis presenting initially as lower limb cellulitis in a renal transplant recipient - a case report. ( 29374464 )
2018
16
Group B Streptococcal Cellulitis and Necrotizing Fasciitis in Infants: A Systematic Review. ( 29424798 )
2018
17
Temporal Expression of Genes in Biofilm-Forming Ocular Candida albicans Isolated From Patients With Keratitis and Orbital Cellulitis. ( 29372251 )
2018
18
Erratum: Extranodal natural killer/T cell lymphoma, nasal type presenting as recurrent facial cellulitis. ( 29451197 )
2018
19
Estimating the health care costs associated with recurrent cellulitis managed in the outpatient setting. ( 29428738 )
2018
20
Orbital Cellulitis in a Psoriatic Patient Treated With Adalimumab. ( 28290979 )
2017
21
Orbital Perivenous Abscess Complicating the Diagnosis and Management of Orbital Cellulitis. ( 28481768 )
2017
22
Skin surface temperatures measured by thermal imaging aid in the diagnosis of cellulitis. ( 28951240 )
2017
23
Clinical profile and outcomes of management of orbital cellulitis in Upper Egypt. ( 28275981 )
2017
24
Case of recurrent severe cellulitis and cutaneous candidiasis during psoriasis treatment with ustekinumab. ( 28432713 )
2017
25
No Benefit with Addition of TMP/SMX to Cephalexin for Nonpurulent Cellulitis. ( 28925641 )
2017
26
Bullous Pesentation of Idiopathic Wells Syndrome (Eosinophilic Cellulitis). ( 28920134 )
2017
27
Hospital costs for patients with lower extremity cellulitis: a retrospective population-based study. ( 28944703 )
2017
28
Orbital Cellulitis Following Uncomplicated Aqueous Shunt Surgery. ( 28557827 )
2017
29
The Penicillin for the Emergency Department Outpatient treatment of CELLulitis (PEDOCELL) trial: update to the study protocol and detailed statistical analysis plan (SAP). ( 28836993 )
2017
30
Serum anti-oxidative reserves during cellulitis: a pilot study. ( 28862136 )
2017
31
Orbital Cellulitis. ( 29248536 )
2017
32
Necrotic Intraocular Retinoblastoma Associated With Orbital Cellulitis. ( 28254446 )
2017
33
Hyaluronidase allergy mimicking orbital cellulitis. ( 29053033 )
2017
34
Sarcoidosis and Wound Healing After Cellulitis of the Lower Limb: Is Methotrexate Responsible for Skin Graft Failure? ( 28862976 )
2017
35
Paediatric orbital cellulitis and the relationship to underlying sinonasal anatomy on computed tomography. ( 28683847 )
2017
36
Orbital cellulitis due to ophthalmic herpes zoster in an immunocompetent child: A case report. ( 28802683 )
2017
37
An Unusual Case of Acute Chondrocalcinosis in Wrist Joint Presenting as Cellulitis. ( 29441250 )
2017
38
Disseminated<i>Pasteurella multocida</i>infection: Cellulitis, osteomyelitis, and myositis. ( 28966913 )
2017
39
Clinical characteristics associated with days to discharge among patients admitted with a primary diagnosis of lower limb cellulitis. ( 28089727 )
2017
40
Spontaneous Rupture of Lacrimal Gland Pleomorphic Adenoma: Pivotal Role in Masquerading Orbital Cellulitis. ( 29049099 )
2017
41
Orbital Cellulitis Presenting as Giant Cell Arteritis: A Case Report. ( 29250759 )
2017
42
Chronic Helicobacter cinaedi cellulitis diagnosed by microbial polymerase chain reaction. ( 28884138 )
2017
43
Molecular Characterization of Staphylococcus aureus Isolates From Children With Periorbital or Orbital Cellulitis. ( 28575438 )
2017
44
Odontogenic orbital cellulitis associated with cavernous sinus thrombosis and pulmonary embolism: a case report. ( 28629401 )
2017
45
Infective Endocarditis Presenting as Bilateral Orbital Cellulitis: An Unusual Case. ( 28721318 )
2017
46
Management of impetigo and cellulitis: Simple considerations for promoting appropriate antibiotic use in skin infections. ( 28807958 )
2017
47
<i>Pasteurella</i> infections in a tertiary centre - from cellulitis to multiple-organ failure: Retrospective case series. ( 29318015 )
2017
48
Risk factors for amendment in type, duration and setting of prescribed outpatient parenteral antimicrobial therapy (OPAT) for adult patients with cellulitis: a retrospective cohort study and CART analysis. ( 28874503 )
2017
49
Orbital Cellulitis Following Orbital Blow-out Fracture. ( 28806382 )
2017
50
Scabies, Periorbital Cellulitis and Recurrent Skin Abscesses due to Panton-Valentine Leukocidin Positive S. aureus Mimic Hyper IgE Syndrome in an Infant. ( 28938255 )
2017

Variations for Cellulitis

Expression for Cellulitis

Search GEO for disease gene expression data for Cellulitis.

Pathways for Cellulitis

GO Terms for Cellulitis

Cellular components related to Cellulitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.5 CAMP CHI3L1 CRP DEFB4A IL5 RNASE3
2 extracellular region GO:0005576 9.28 CAMP CHI3L1 CRP DEFB4A FLT4 IL1R1

Biological processes related to Cellulitis according to GeneCards Suite gene sharing:

(show all 12)
# Name GO ID Score Top Affiliating Genes
1 immune response GO:0006955 9.81 DEFB4A IL1R1 IL5 TNF
2 inflammatory response GO:0006954 9.76 CHI3L1 CRP IL5 TNF
3 defense response GO:0006952 9.65 CAMP DEFB4A TNF
4 defense response to bacterium GO:0042742 9.56 CAMP DEFB4A RNASE3 TNF
5 defense response to Gram-negative bacterium GO:0050829 9.54 CAMP DEFB4A RNASE3
6 innate immune response in mucosa GO:0002227 9.49 CAMP RNASE3
7 negative regulation of growth of symbiont in host GO:0044130 9.43 CAMP TNF
8 positive regulation of podosome assembly GO:0071803 9.4 IL5 TNF
9 antimicrobial humoral response GO:0019730 9.33 CAMP DEFB4A RNASE3
10 negative regulation of lipid storage GO:0010888 9.32 CRP TNF
11 antimicrobial humoral immune response mediated by antimicrobial peptide GO:0061844 9.13 CAMP DEFB4A RNASE3
12 defense response to Gram-positive bacterium GO:0050830 9.02 CAMP CRP DEFB4A RNASE3 TNF

Sources for Cellulitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....